The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals. | Blood;98(2): 383-9, 2001 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals.

Chavan, S; Kodoth, S; Pahwa, R; Pahwa, S.

Affiliation

Chavan S; Division of Allergy/Immunology, Department of Pediatrics, North Shore University Hospital, New York University School of Medicine, Manhasset, NY 11030, USA.

Blood ; 98(2): 383-9, 2001 Jul 15.

Article in En | MEDLINE | ID: mdl-11435307

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes / HIV Infections / Cell Cycle / HIV Protease Inhibitors / Indinavir Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Journal: Blood Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Lymphocytes / HIV Infections / Cell Cycle / HIV Protease Inhibitors / Indinavir Limits: Adolescent / Child / Child, preschool / Humans / Infant Language: En Journal: Blood Year: 2001 Document type: Article Affiliation country: